Plain-English translation of NCT05022238 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers in Namibia are studying drug-resistant tuberculosis—a serious form of TB that doesn't respond to standard antibiotics—to understand how it spreads in communities. The study will collect information from TB patients, their household members, hospital visitors, and community members to map where the disease is most common and test new ways to find cases earlier.
Drug-resistant tuberculosis is a growing epidemic worldwide, and Namibia has a high number of cases. Current methods aren't catching all patients, which means the disease continues to spread. This study aims to find better ways to identify cases quickly and understand transmission patterns so doctors can intervene sooner.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share health and social information about yourself, your contacts, and your living situation with researchers. The study team will collect clinical, epidemiological, and social network data from TB patients and their close contacts across three regions. Researchers will also use genetic testing to better understand the TB strains and how they relate to one another.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Namibia